Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: How should we conciliate these new findings with the Zephyr trial results?

Critical Care Medicine

Volumn 39, Issue 8, 2011, Pages 2009-2010

  Kalil, Andre C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Linezolid; pneumonia; vancomycin

Indexed keywords

GELATINASE B; INTERLEUKIN 6; LINEZOLID; MONOCYTE CHEMOTACTIC PROTEIN 5; VANCOMYCIN;

APOPTOSIS; CLINICAL TRIAL (TOPIC); EDITORIAL; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTENSIVE CARE; LEUKOCYTE; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; META ANALYSIS (TOPIC); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC);

EID: 79961086745     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318221741c     Document Type: Editorial

References (11)

1. Akinnusi ME, Hattemer A, Gao W, et al: Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia? Crit Care Med 2011; 39:1944-1952
2. Kunkel M, Chastre JE, Kollef M, et al: Linezolid vs. vancomycin in the treatment of nosocomial pneumonia proven due to methicillin-resistant Staphylococcus aureus (oral Abstr). Presented at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA). October 21-24, 2010, Vancouver, BC, Canada
3. Kiem S, Schentag JJ: Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob Agents Chemother 2008; 52:24-36
4. Kalil AC, Murthy MH, Hermsen ED, et al: Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis. Crit Care Med 2010; 38:1802-1808
5. Montori VM, Guyatt GH: Intention-to-treat principle. CMAJ 2001; 165:1339-1341 (Pubitemid 33044065)
6. Liu C, Bayer A, Cosgrove SE, et al: Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children: Executive summary. Clin Infect Dis 2011; 52:285-292
7. Wunderink RG, Rello J, Cammarata SK, et al: Linezolid vs vancomycin: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124: 1789-1797 (Pubitemid 37433574)
8. Kalil AC, Puumala SE, Stoner J: Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia. Chest 2004;125:2370-2371 (Pubitemid 38788219)
9. U.S. Food and Drug Administration: ZYVOX® (linezolid) injection, tablets, and oral suspension. Available at: http://www.fda. gov/downloads/Drugs/ GuidanceCompliance-RegulatoryInformation/EnforcementActivitiesby FDA/WarningLettersandNoticeofViolation LetterstoPharmaceuticalCompanies/ucm 054813.pdf. Accessed May 6, 2011
10. U.S. Department of Health & Human Services: Justice Department announces largest health care fraud settlement in its history: Pfizer to pay $2.3 billion for fraudulent marketing. Available at: http://www.hhs.gov/news/press/2009pres/09/20090902a.html. Accessed May 6, 2011
11. Kalil AC, Sun J: Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis. PLoS One 2008; 3:e2291